These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3480077)

  • 1. Proliferation kinetics of plasma cells and of normal haemopoietic cells in multiple myeloma.
    Ucci G; Riccardi A; Dörmer P; Danova M; Luoni R; Montecucco CM; Ciotti R; Girino M
    Cell Tissue Kinet; 1987 May; 20(3):311-8. PubMed ID: 3480077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
    Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ;
    Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early plasma cell recruitment in multiple myeloma following chemotherapy.
    Ucci G; Riccardi A; Dörmer P; Danova M; Luoni R
    Cell Tissue Kinet; 1988 Nov; 21(6):405-9. PubMed ID: 3251633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy.
    Boccadoro M; Gavarotti P; Fossati G; Pileri A; Marmont F; Neretto G; Gallamini A; Volta C; Tribalto M; Testa MG
    Br J Haematol; 1984 Dec; 58(4):689-96. PubMed ID: 6518137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantation.
    Rajkumar SV; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Therneau TM; Kyle RA; Greipp PR; Gertz MA
    Am J Hematol; 2001 Dec; 68(4):269-75. PubMed ID: 11754416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
    Sezer O; Heider U; Zavrski I; Possinger K
    Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate and time of DNA synthesis of human leukaemic blasts in bone marrow and peripheral blood.
    Ucci G; Riccardi A; Dörmer P; Danova M
    Cell Tissue Kinet; 1986 Jul; 19(4):429-35. PubMed ID: 3464354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth kinetics of plasma cell myeloma.
    Drewinko B; Alexanian R
    J Natl Cancer Inst; 1977 May; 58(5):1247-53. PubMed ID: 857025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma.
    Riccardi A; Ucci G; Luoni R; Castello A; Coci A; Magrini U; Ascari E
    J Clin Pathol; 1990 Jun; 43(6):469-75. PubMed ID: 2199532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma.
    Chakraborty R; Muchtar E; Kumar SK; Buadi FK; Dingli D; Dispenzieri A; Hayman SR; Hogan WJ; Kapoor P; Lacy MQ; Leung N; Gertz MA
    Leuk Lymphoma; 2017 Feb; 58(2):308-315. PubMed ID: 27390076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 dependence of advanced malignant plasma cell dyscrasias.
    Zhang XG; Bataille R; Widjenes J; Klein B
    Cancer; 1992 Mar; 69(6):1373-6. PubMed ID: 1540875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argyrophilic nucleolar organizer region counts in multiple myeloma: a histopathological study on bone marrow trephine biopsies.
    Pich A; Chiusa L; Marmont F; Cappello N; Navone R
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(2):143-7. PubMed ID: 1514245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody Ki-67 as a marker of proliferative activity in monoclonal gammopathies.
    Girino M; Riccardi A; Luoni R; Ucci G; Cuomo A
    Acta Haematol; 1991; 85(1):26-30. PubMed ID: 2011926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections.
    Pellegrini W; Facchetti F; Marocolo D; Salvi L; Capucci A; Tironi A; Rossi G
    Histopathology; 1995 Nov; 27(5):397-405. PubMed ID: 8575729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form.
    Rago A; Grammatico S; Za T; Levi A; Mecarocci S; Siniscalchi A; De Rosa L; Felici S; Bongarzoni V; Piccioni AL; La Verde G; Pisani F; Franceschini L; Paviglianiti AL; Caravita T; Petrucci MT; De Stefano V; Cimino G;
    Cancer; 2012 Nov; 118(22):5544-9. PubMed ID: 22786730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cell proliferation in monoclonal gammopathies: measurement using BU-1 antibody in flow cytometry and microscopy: comparison with serum thymidine kinase.
    Schambeck CM; Wick M; Bartl R; Lamerz R; Fateh-Moghadam A
    J Clin Pathol; 1995 May; 48(5):477-81. PubMed ID: 7629298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of serum stimulation and plasma cell proliferation during chemotherapy of multiple myeloma.
    Karp JE; Burke PJ; Humphrey RL
    Blood; 1977 Jun; 49(6):925-34. PubMed ID: 861376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
    Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G
    J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cell morphology in multiple myeloma and related disorders.
    Ribourtout B; Zandecki M
    Morphologie; 2015 Jun; 99(325):38-62. PubMed ID: 25899140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunofluorescent plasma cell labeling indices (LI) using a monoclonal antibody (BU-1).
    Greipp PR; Witzig TE; Gonchoroff NJ
    Am J Hematol; 1985 Nov; 20(3):289-92. PubMed ID: 3904417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.